Does tirofiban improve safety and late survival in patients with acute moderate ischemic stroke?
Tirofiban appears safe and may improve late survival in patients with acute moderate ischemic stroke, even with delayed administration.
We conclude that tirofiban might be safe in acute moderate ischemic stroke even when administered within a large time window after symptom onset and might save lives in the late outcome. Clinical Trial Registration- URL: www.strokecenter.org/trials/. Trial name: SaTIS. Enrollment began before July 1, 2005.
Siebler et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: